Skip to main content
Akso Health Group logo

Akso Health Group — Investor Relations & Filings

Ticker · AHG ISIN · US98422P1084 LEI · 5493007BHBTZESVSIA24 US Human health and social work activities
Open in API
Filings indexed 190 across all filing types
Latest filing 2025-01-06 Regulatory Filings
Country KY Cayman Islands
Listing US AHG

About Akso Health Group

https://www.ahgtop.com/en/index.html

Akso Health Group operates a social e-commerce platform that collaborates with other domestic e-commerce platforms to offer users a wide selection of products. The company is also developing a new business as a cancer therapy and radiotherapy oncology service provider. This expansion includes plans to open vaccine research centers and radiation oncology centers. These facilities will offer specialized radiation therapy, personalized consultation, conventional treatment planning, and other cancer-related treatment services for patients in need of varying stages of care.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings Classification · 95% confidence The document is a correspondence letter from Akso Health Group to the SEC Division of Corporation Finance responding to comments on an Amendment No. 1 to a Registration Statement on Form F-3. It discusses legal opinions, exhibit filings, and disclosure revisions related to the registration statement. The content is focused on regulatory compliance and responses to SEC staff comments rather than presenting financial data or report content. The document length is 4053 characters, which is relatively short and primarily a regulatory correspondence. It does not contain financial statements or detailed report data, nor is it an announcement of a report publication. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements, compliance documents, and correspondence with regulatory bodies that do not fit other categories.
2025-01-06 English
Regulatory Filings 2024
Regulatory Filings
2024-12-17 English
AMENDMENT NO. 1 TO FORM F-3
Capital/Financing Update Classification · 95% confidence The document is titled 'Amendment No. 1 to Form F-3' and is a registration statement filed with the U.S. Securities and Exchange Commission (SEC) under the Securities Act of 1933. It is a prospectus for a shelf registration allowing the company to offer securities up to $400 million. The document includes detailed information about the securities, risk factors, use of proceeds, and legal matters. Form F-3 is a type of registration statement used for securities offerings, not a financial report like an annual or quarterly report. This document is a capital/financing update related to the company's securities offering and registration with the SEC. It is not an earnings release, annual report, or other financial statement. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a full registration statement amendment, not just an announcement or certification, supporting a high confidence score.
2024-11-26 English
WITHDRAWAL REQUEST
Regulatory Filings Classification · 100% confidence The document is a formal letter addressed to the U.S. Securities and Exchange Commission requesting the withdrawal of an Amendment No.1 to a Registration Statement on Form F-3. It references regulatory rules under the Securities Act of 1933 and discusses the withdrawal process and fee crediting. There is no financial data, report content, or presentation material included. The document is a regulatory procedural filing related to the withdrawal of a registration statement, not a financial report or announcement of financial results. Given the nature and content, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2024-11-26 English
AMENDMENT NO. 1 TO FORM F-3
Capital/Financing Update Classification · 100% confidence The document is titled 'Amendment No. 1 to Form F-3' and is a registration statement filed with the SEC under the Securities Act of 1933. It is a prospectus for a shelf registration allowing the company to offer securities up to $400 million. The document includes detailed descriptions of securities, risk factors, use of proceeds, and other offering-related information. This type of filing is a capital raising document related to financing activities, specifically a registration statement for securities offerings. It is not an earnings release, annual report, or other financial report. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS.
2024-11-21 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, Akso Health Group, submitted to the SEC. It contains detailed information about a private placement financing transaction, business updates, strategic plans, and revenue models. The Form 6-K is a report used by foreign private issuers to disclose material information between annual reports (20-F or 40-F). This filing is not an annual report, earnings release, or other specific report type but rather a regulatory filing providing material updates and disclosures. The document length is substantial and contains substantive business and financial information, but it is not a full financial report like a 10-K or interim report. Therefore, the appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings such as Form 6-K reports that do not fit other categories.
2024-11-08 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.